Senseye, Inc. Overview
Pro stress-test →Senseye is an AI-driven computational neuroscience company that uses smartphones to capture video of the eye, delivering highly accurate and objective data about an individual's mental health. The company is pioneering a breakthrough diagnostic platform for mental health, focusing initially on PTSD, and aims to empower clinicians with fast, accurate tools to personalize care by establishing clear baselines and tracking outcomes over time.
Strategic Profile
Pro stress-test →Senseye leverages brain-based diagnostics and computer vision technology to transform the diagnostic process for PTSD, anxiety, depression, and addiction into an objective process. The diagnostic runs on smartphones from any location—including telehealth settings—with no specialized equipment or upfront capital investment needed, creating significant accessibility and scalability advantages in mental health diagnostics.
Competitive Landscape
Pro stress-test →Senseye competes with BrainCheck and similar neurotechnology platforms in mental health diagnostics. The market faces competition from traditional psychiatric assessment tools and emerging digital biomarker companies, but Senseye's smartphone-first architecture and ocular biomarker focus create differentiation. Strategic investor Topcon Healthcare has invested in Senseye, reflecting sector confidence in ocular-based mental health diagnostics powered by AI and computer vision.
Industry Context
Senseye, Inc. operates in Digital mental health diagnostics and biomarkers.
Key facts
Founded: 2015 · Headquarters: Austin, Texas, US · Employees: 11–50 · Revenue: N/A · Market cap: N/A